Surat-based Anupam Rasayan India Ltd said it was acquiring up to 74.2 per cent in Bliss GVS Pharma Ltd, a Mumbai-based formulations company. A provider of custom synthesis and specialty chemicals Anupam Rasayan said in a statement it was picking up 43.3-48.2 per cent equity stake, followed by an open offer to the public shareholders of Bliss GVS Pharma Limited, at a reported cost of ?1,360-plus crore. The company plans to acquire shares at Rs 299 per share. The acquisition will be funded through a Rs 300 crore term loan, with the remaining amount financed via a non-controlling, non-voting equity…